CME Group (Nasdaq: CME) releases Q4 and full-year 2025 results

Rhea-AI Filing Summary

CME Group Inc. filed a current report to furnish its earnings press release for the quarter and year ended December 31, 2025. The press release, dated February 4, 2026, is attached as Exhibit 99.1 and outlines the company’s financial results.

The release includes several non-GAAP financial measures, such as adjusted revenues, expenses, operating income, net income and earnings per share. Management states these are intended to supplement GAAP results and improve comparability with prior periods, and provides reconciliations to the most directly comparable GAAP figures in accordance with Regulation G.

false000115637500011563752026-02-042026-02-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

_________________________________________________________

FORM 8-K

_________________________________________________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) February 4, 2026

 _________________________________________________________

CME GROUP INC.

(Exact Name of Registrant as Specified in its Charter) 

_________________________________________________________ 

Delaware

001-31553

36-4459170

(State or Other Jurisdiction of Incorporation)

(Commission File No.)

(IRS Employer Identification No.)

20 South Wacker Drive

Chicago

Illinois

60606

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report) 

______________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading symbol			Name of each exchange on which registered
Class A Common Stock			CME			Nasdaq

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated February 4, 2026, reporting CME Group Inc.’s financial results for the quarter and year ended December 31, 2025.

To supplement CME Group’s financial statements on a GAAP basis, the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share. Management believes that the presentation of non-GAAP revenues, expenses, operating income, net income and earnings per share provide important supplemental information to management and investors about financial and business trends relating to CME Group Inc.’s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provide a better measure of comparability with the Company’s prior financial reports. Management acknowledges that non-GAAP adjustments may include recurring items. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Pursuant to the requirements of Regulation G, CME Group Inc. has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in the press release.

Item 9.01 Financial Statements and Exhibits.

Exhibit Number						Description
99.1						Press Release, dated February 4, 2026.
104						The cover page from CME Group Inc.'s Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CME Group Inc.

Registrant

Date: February 4, 2026

By:

/s/ Lynne Fitzpatrick

Name: Title:

Lynne Fitzpatrick Senior Managing Director, President and Chief Financial Officer Principal Financial Offer and Duly Authorized Officer

FAQ

What event does CME (CME) report in this 8-K filing?

CME Group Inc. reports that it has issued a press release with financial results for the quarter and year ended December 31, 2025. The 8-K simply furnishes this earnings release as Exhibit 99.1 for investors and regulators.

What is included in CME (CME) Exhibit 99.1?

Exhibit 99.1 is a press release dated February 4, 2026, detailing CME Group Inc.’s financial results for the quarter and full year ended December 31, 2025. It also contains non-GAAP financial measures with reconciliations to the most comparable GAAP figures.

Which non-GAAP measures does CME (CME) highlight in its earnings release?

The earnings release highlights non-GAAP revenues, expenses, operating income, net income and earnings per share. Management explains these measures are used to provide supplemental insight into financial and business trends and to enhance comparability with CME Group’s prior financial reports.

How does CME (CME) address Regulation G for non-GAAP figures?

CME Group Inc. states that, under Regulation G, it includes reconciliations of each non-GAAP financial measure to the most directly comparable GAAP measure. This aims to ensure transparency when presenting adjusted revenues, expenses, operating income, net income and earnings per share.